Cargando…

Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy

The combined-immunotherapy of adoptive cell therapy (ACT) and cyclophosphamide (CTX) is one of the most efficient treatments for melanoma patients. However, no synergistic effects of CTX and ACT on the spatio-temporal dynamics of immunocytes in vivo have been described. Here, we visualized key cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Shuhong, Li, Hui, Lu, Lisen, Qi, Zhongyang, Liu, Lei, Chen, Lu, Shen, Guanxin, Fu, Ling, Luo, Qingming, Zhang, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173323/
https://www.ncbi.nlm.nih.gov/pubmed/27855783
http://dx.doi.org/10.7554/eLife.14756
_version_ 1782484304415162368
author Qi, Shuhong
Li, Hui
Lu, Lisen
Qi, Zhongyang
Liu, Lei
Chen, Lu
Shen, Guanxin
Fu, Ling
Luo, Qingming
Zhang, Zhihong
author_facet Qi, Shuhong
Li, Hui
Lu, Lisen
Qi, Zhongyang
Liu, Lei
Chen, Lu
Shen, Guanxin
Fu, Ling
Luo, Qingming
Zhang, Zhihong
author_sort Qi, Shuhong
collection PubMed
description The combined-immunotherapy of adoptive cell therapy (ACT) and cyclophosphamide (CTX) is one of the most efficient treatments for melanoma patients. However, no synergistic effects of CTX and ACT on the spatio-temporal dynamics of immunocytes in vivo have been described. Here, we visualized key cell events in immunotherapy-elicited immunoreactions in a multicolor-coded tumor microenvironment, and then established an optimal strategy of metronomic combined-immunotherapy to enhance anti-tumor efficacy. Intravital imaging data indicated that regulatory T cells formed an 'immunosuppressive ring' around a solid tumor. The CTX-ACT combined-treatment elicited synergistic immunoreactions in tumor areas, which included relieving the immune suppression, triggering the transient activation of endogenous tumor-infiltrating immunocytes, increasing the accumulation of adoptive cytotoxic T lymphocytes, and accelerating the infiltration of dendritic cells. These insights into the spatio-temporal dynamics of immunocytes are beneficial for optimizing immunotherapy and provide new approaches for elucidating the mechanisms underlying the involvement of immunocytes in cancer immunotherapy. DOI: http://dx.doi.org/10.7554/eLife.14756.001
format Online
Article
Text
id pubmed-5173323
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-51733232016-12-23 Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy Qi, Shuhong Li, Hui Lu, Lisen Qi, Zhongyang Liu, Lei Chen, Lu Shen, Guanxin Fu, Ling Luo, Qingming Zhang, Zhihong eLife Cancer Biology The combined-immunotherapy of adoptive cell therapy (ACT) and cyclophosphamide (CTX) is one of the most efficient treatments for melanoma patients. However, no synergistic effects of CTX and ACT on the spatio-temporal dynamics of immunocytes in vivo have been described. Here, we visualized key cell events in immunotherapy-elicited immunoreactions in a multicolor-coded tumor microenvironment, and then established an optimal strategy of metronomic combined-immunotherapy to enhance anti-tumor efficacy. Intravital imaging data indicated that regulatory T cells formed an 'immunosuppressive ring' around a solid tumor. The CTX-ACT combined-treatment elicited synergistic immunoreactions in tumor areas, which included relieving the immune suppression, triggering the transient activation of endogenous tumor-infiltrating immunocytes, increasing the accumulation of adoptive cytotoxic T lymphocytes, and accelerating the infiltration of dendritic cells. These insights into the spatio-temporal dynamics of immunocytes are beneficial for optimizing immunotherapy and provide new approaches for elucidating the mechanisms underlying the involvement of immunocytes in cancer immunotherapy. DOI: http://dx.doi.org/10.7554/eLife.14756.001 eLife Sciences Publications, Ltd 2016-11-18 /pmc/articles/PMC5173323/ /pubmed/27855783 http://dx.doi.org/10.7554/eLife.14756 Text en © 2016, Qi et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cancer Biology
Qi, Shuhong
Li, Hui
Lu, Lisen
Qi, Zhongyang
Liu, Lei
Chen, Lu
Shen, Guanxin
Fu, Ling
Luo, Qingming
Zhang, Zhihong
Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
title Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
title_full Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
title_fullStr Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
title_full_unstemmed Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
title_short Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
title_sort long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173323/
https://www.ncbi.nlm.nih.gov/pubmed/27855783
http://dx.doi.org/10.7554/eLife.14756
work_keys_str_mv AT qishuhong longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT lihui longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT lulisen longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT qizhongyang longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT liulei longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT chenlu longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT shenguanxin longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT fuling longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT luoqingming longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy
AT zhangzhihong longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy